Stockscreener 앱 받기
18.05
3.32%
0.58
시간 외 거래:
18.82
0.77
+4.27%
Arcus Biosciences Inc 주식(RCUS)의 최신 뉴스
Using AI based signals to follow Arcus Biosciences Inc.Weekly Volume Report & Entry Point Confirmation Signals - newser.com
Analyzing recovery setups for Arcus Biosciences Inc. investors2025 Valuation Update & Advanced Technical Analysis Signals - newser.com
Arcus Biosciences Inc. recovery potential after sell offMarket Performance Recap & Long-Term Safe Return Strategies - newser.com
Why Arcus Biosciences Inc. stock appears on watchlistsTrade Entry Report & Consistent Profit Alerts - newser.com
Is Arcus Biosciences Inc. stock safe for risk averse investorsQuarterly Market Review & Fast Gaining Stock Reports - newser.com
Should you hold or exit Arcus Biosciences Inc. nowEarnings Overview Report & Technical Pattern Based Signals - newser.com
Is this a good reentry point in Arcus Biosciences Inc.July 2025 Highlights & Entry Point Confirmation Signals - newser.com
How moving averages guide Arcus Biosciences Inc. tradingJuly 2025 WrapUp & Daily Volume Surge Signals - newser.com
RCUS: Wells Fargo Raises Price Target on Arcus Biosciences to $2 - GuruFocus
Published on: 2025-10-20 09:03:52 - newser.com
Applying sector rotation models to Arcus Biosciences Inc.Market Trend Summary & Daily Technical Forecast Reports - newser.com
Published on: 2025-10-20 00:14:27 - newser.com
Taiho Exercises Option for Casdatifan Development with Arcus (RC - GuruFocus
Will Arcus Biosciences Inc. stock benefit from sector rotationJuly 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com
Exclusive license for casdatifan in Japan & select Asian territories — Taiho exercises option from Arcus - Stock Titan
Arcus Biosciences Hits Day High with Strong 8.19% Intraday Surge - Markets Mojo
Arcus Biosciences Hits Day High with 13.97% Surge Amid Market Decline - Markets Mojo
What analysts say about Arcus Biosciences Inc stockGlobal Trade Effects & Fast Growing Trading Plans - earlytimes.in
Visual analytics tools that track Arcus Biosciences Inc. performanceWeekly Risk Report & Verified Entry Point Signals - newser.com
Will Arcus Biosciences Inc. outperform the marketEarnings Growth Summary & Entry Point Strategy Guides - newser.com
Movement Recap: Will Arcus Biosciences Inc. stock benefit from sector rotation2025 Buyback Activity & AI Forecast Swing Trade Picks - nchmf.gov.vn
Can momentum traders help lift Arcus Biosciences Inc.Portfolio Profit Report & Fast Moving Stock Watchlists - newser.com
Why Arcus Biosciences Inc. stock is rated strong buyQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com
Growth Recap: Will Arcus Biosciences Inc. stock benefit from sector rotationJuly 2025 Institutional & Risk Managed Investment Entry Signals - nchmf.gov.vn
Can Arcus Biosciences Inc. stock deliver consistent EPS growthJuly 2025 Earnings & Fast Gaining Stock Reports - nchmf.gov.vn
Arcus Biosciences: Refusing To Let The TIGIT Story Die, And Finding Potential Niches In Huge Markets - Seeking Alpha
Arcus data throw TIGIT a lifeline: Clinical Report - biocentury.com
What dividend safety score for Arcus Biosciences Inc. stockMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Arcus Biosciences reports Phase 2 survival data for gastric cancer study - Investing.com Australia
Arcus’s ‘Last TIGIT Standing’ Shows Phase II Survival Benefit - Citeline News & Insights
Arcus Biosciences Reports Promising Phase 2 Study Results - TipRanks
Arcus Biosciences reports Phase 2 survival data for gastric cancer study By Investing.com - Investing.com South Africa
2.32%
1.34%
자본화:
|
볼륨(24시간):